Amarjot Kaur

[4] Before joining Merck, Kaur earned her Ph.D. at Panjab University in Chandigarh, India,[5] where she also worked as a lecturer.

[2] At Panjab, in the 1990s, Kaur published research in mathematical statistics on tests for stochastic dominance.

[T2O] She joined Merck after postdoctoral research at Pennsylvania State University.

[2] At Merck, she became the chief statistician on the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme, a large international study of treatments for arthritis.

[CVO] In 2014, she was elected to be a Fellow of the American Statistical Association.